Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04835844 · ClinicalTrials.gov registry record
RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation
A clinical trial of Paroxysmal Atrial Fibrillation, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 49
- Enrollment target
- 1
- Study location
NCT04835844 is a study of Paroxysmal Atrial Fibrillation that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 49 participants, below the 857-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04835844, a study of Paroxysmal Atrial Fibrillation, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
The MAP-AF study will compare RHYTHMIA vs CARTO in redo ablation of paroxysmal AF with assessment of both acute procedural profiles and clinical outcomes.
Conditions Studied
Interventions
- DEVICE CARTO
- DEVICE RHYTHMIA
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2020-07-24 |
| Est. Completion | 2026-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04835844
The ClinicalTrials.gov registry entry for NCT04835844 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 857-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (94% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which CARTO is the first listed.
NCT04835844 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04835844 about?
NCT04835844 is a clinical study titled "RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation". The MAP-AF study will compare RHYTHMIA vs CARTO in redo ablation of paroxysmal AF with assessment of both acute procedural profiles and clinical outcomes.
What is the current status of trial NCT04835844?
This trial is currently active not recruiting. The enrollment target is 49 participants. The study started on 2020-07-24. Estimated completion is 2026-07-01.
What conditions does trial NCT04835844 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation.
What interventions are being tested in trial NCT04835844?
The interventions under investigation include: CARTO (DEVICE), RHYTHMIA (DEVICE).
Who is sponsoring clinical trial NCT04835844?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04835844 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
RECRUITING
-
STOP AF First Post-Approval Study
RECRUITING
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RECRUITING
-
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
RECRUITING
-
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.